BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Deals

  Dragon Pharmaceuticals Inc. Sells Polymun Scientific Immunbiologische Forschung GmbH Development And Manufacturing Agreement For US$ 1 Million

  February 2, 2006

   · 

  3 min read
• Business

  Startup Biotech Mithridion, Inc. Lands Funding

  February 2, 2006

   · 

  1 min read
• FDA

  Pfizer Inc. Release: European Commission Approves Macugen For Treatment Of All Types Of Wet Age-Related Macular Degeneration; First Treatment To Target Underlying Disease Process Of Wet AMD

  February 2, 2006

   · 

  4 min read
• Business

  Amorfix Life Sciences Ltd. In-Licenses Novel Technology To Begin Therapeutic Program For Neurodegenerative Diseases

  February 2, 2006

   · 

  1 min read
• Business

  AtheroGenics Extends Research And Development Collaboration With Astellas Pharma Inc.

  February 2, 2006

   · 

  1 min read
• Policy

  APOXIS S.A. Receives FDA Orphan Medicinal Product Designation For APO200 For The Treatment Of XLHED

  February 2, 2006

   · 

  1 min read
• Deals

  Somanta Pharmaceuticals, Inc. Completes Merger And Raises $5.9 Million In Private Placement Financing

  February 2, 2006

   · 

  1 min read
• Business

  Galapagos Genomics NV And BASF AG Extend Research Collaborations

  February 2, 2006

   · 

  1 min read
• Business

  BurnsAdler Pharmaceuticals, Inc. Expands Puerto Rico Franchise; Partners With QOL Medical For Sucraid

  February 2, 2006

   · 

  1 min read
• Business

  BurnsAdler Pharmaceuticals, Inc. Licenses Anti-Epileptic Portfolio From Desitin Arzneimittel GmbH

  February 2, 2006

   · 

  1 min read